Warren S. Wade

1.3k total citations
24 papers, 1.1k citations indexed

About

Warren S. Wade is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Warren S. Wade has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Warren S. Wade's work include Pharmacological Receptor Mechanisms and Effects (4 papers), DNA and Nucleic Acid Chemistry (4 papers) and Estrogen and related hormone effects (4 papers). Warren S. Wade is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (4 papers), DNA and Nucleic Acid Chemistry (4 papers) and Estrogen and related hormone effects (4 papers). Warren S. Wade collaborates with scholars based in United States, Poland and Austria. Warren S. Wade's co-authors include Peter B. Dervan, Milan Mrksich, Kodi S. Ravichandran, John E. Harlan, Steven J. Burakoff, Ming‐Ming Zhou, Stephen W. Fesik, Robert Meadows, Edward T. Olejniczak and Michael Sattler and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Warren S. Wade

24 papers receiving 1.1k citations

Peers

Warren S. Wade
Asko Uri Estonia
John Porter United Kingdom
Andrew S. Cook United Kingdom
David M. Ryckman United States
Nobuo Cho Japan
Benjamin Greedy United Kingdom
Michael Ohlmeyer United States
Asko Uri Estonia
Warren S. Wade
Citations per year, relative to Warren S. Wade Warren S. Wade (= 1×) peers Asko Uri

Countries citing papers authored by Warren S. Wade

Since Specialization
Citations

This map shows the geographic impact of Warren S. Wade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren S. Wade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren S. Wade more than expected).

Fields of papers citing papers by Warren S. Wade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warren S. Wade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren S. Wade. The network helps show where Warren S. Wade may publish in the future.

Co-authorship network of co-authors of Warren S. Wade

This figure shows the co-authorship network connecting the top 25 collaborators of Warren S. Wade. A scholar is included among the top collaborators of Warren S. Wade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warren S. Wade. Warren S. Wade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bajusz, Dávid, Warren S. Wade, Grzegorz Satała, et al.. (2021). Exploring protein hotspots by optimized fragment pharmacophores. Nature Communications. 12(1). 3201–3201. 31 indexed citations
2.
Wade, Warren S., et al.. (2019). Efficient Synthesis of 3,4-Disubstituted 7-Azaindoles Employing SEM as a Dual Protecting–Activating Group. Synlett. 30(20). 2273–2278. 1 indexed citations
3.
Kiankarimi, Mehrak, Beth A. Fleck, Kathleen R. Gogas, et al.. (2008). Structure–activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability. Bioorganic & Medicinal Chemistry Letters. 18(16). 4491–4494. 6 indexed citations
4.
Chen, Chen, Yongsheng Chen, Joseph Pontillo, et al.. (2008). Potent and orally bioavailable zwitterion GnRH antagonists with low CYP3A4 inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 18(11). 3301–3305. 13 indexed citations
5.
Kiankarimi, Mehrak, et al.. (2008). Synthesis and structure–activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint. Bioorganic & Medicinal Chemistry Letters. 18(16). 4495–4498. 30 indexed citations
6.
Wu, Dongpei, Joseph Pontillo, Yinghong Gao, et al.. (2008). Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI). Bioorganic & Medicinal Chemistry Letters. 18(14). 4224–4227. 23 indexed citations
7.
Pontillo, Joseph, Dongpei Wu, Yinghong Gao, et al.. (2008). Synthesis and structure–activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics. Bioorganic & Medicinal Chemistry Letters. 18(23). 6151–6155. 7 indexed citations
9.
Kiankarimi, Mehrak, Martin W. Rowbottom, Dongpei Wu, et al.. (2006). Synthesis and structure–activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2. Bioorganic & Medicinal Chemistry Letters. 16(18). 4922–4930. 9 indexed citations
10.
Rowbottom, Martin W., Brian Dyck, Mingzhu Zhang, et al.. (2006). Synthesis and structure–activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1. Bioorganic & Medicinal Chemistry Letters. 16(17). 4450–4457. 6 indexed citations
11.
Dyck, Brian, Joseph Pontillo, Christopher E. Heise, et al.. (2006). Substituted chromones and quinolones as potent melanin-concentrating hormone receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(16). 4237–4242. 14 indexed citations
12.
Guo, Zhiqiang, Yongsheng Chen, Charles Q. Huang, et al.. (2005). Uracils as potent antagonists of the human gonadotropin-releasing hormone receptor without atropisomers. Bioorganic & Medicinal Chemistry Letters. 15(10). 2519–2522. 20 indexed citations
13.
Heise, Christopher E., Anil Pahuja, Amy Putnam, et al.. (2005). Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule Antagonist. Journal of Pharmacology and Experimental Therapeutics. 313(3). 1263–1271. 68 indexed citations
14.
Ott, Thomas, Anil Pahuja, Francisco M. Lio, et al.. (2004). A high-throughput chemotaxis assay for pharmacological characterization of chemokine receptors: Utilization of U937 monocytic cells. Journal of Pharmacological and Toxicological Methods. 51(2). 105–114. 11 indexed citations
15.
Wade, Warren S., Fan Yang, & Thomas J. Sowin. (2000). Application of Base Cleavable Safety Catch Linkers to Solid Phase Library Production. Journal of Combinatorial Chemistry. 2(3). 266–275. 16 indexed citations
16.
Zhou, Ming‐Ming, John E. Harlan, Warren S. Wade, et al.. (1995). Binding Affinities of Tyrosine-phosphorylated Peptides to the COOH-terminal SH2 and NH2-terminal Phosphotyrosine Binding Domains of Shc. Journal of Biological Chemistry. 270(52). 31119–31123. 49 indexed citations
17.
Zhou, Ming‐Ming, Kodi S. Ravichandran, Edward T. Olejniczak, et al.. (1995). Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature. 378(6557). 584–592. 309 indexed citations
19.
Wade, Warren S., et al.. (1993). Engineering metal coordination sites into the antibody light chain. Journal of the American Chemical Society. 115(11). 4449–4456. 39 indexed citations
20.
Wade, Warren S. & Peter B. Dervan. (1987). Alteration of the sequence specificity of distamycin on DNA by replacement of an N-methylpyrrolecarboxamide with pyridine-2-carboxamide. Journal of the American Chemical Society. 109(5). 1574–1575. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026